Eli Lilly’s experimental obesity pill, orforglipron, met its main goals in a closely watched late-stage trial,…
A growing number of UK travellers are turning away from the Mediterranean in the peak summer…
Eli Lilly’s experimental obesity pill, orforglipron, met its main goals in a closely watched late-stage trial,…
The US dollar index remains under pressure this week as the market focused on the latest…
A growing number of UK travellers are turning away from the Mediterranean in the peak summer…
The Xiaomi stock price has pulled back in the past few weeks as investors focus on…
The specter of costly trade tariffs, once a painful memory for businesses like UK advanced materials…
Semiconductor stocks have pulled back this year, hurting top exchange-traded funds that have long provided growth…
European stock markets kicked off the week on a positive note Monday, as investors grasped onto…
The Neos S&P 500 High Income (SPYI) ETF has retreated this year as American stocks dived…
Ageas has agreed to acquire British insurer Esure for £1.3 billion, in a move that will…
Goldman Sachs, a leading global investment bank, has revised its year-end gold price forecast upwards to…